Expression and Function of
Animals
CRISPR-Cas Systems
Cell Line, Tumor
Cell Nucleus
/ genetics
Down-Regulation
Epithelial-Mesenchymal Transition
/ genetics
Female
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Gene Knockdown Techniques
Humans
MCF-7 Cells
Mice
MicroRNAs
/ genetics
Promoter Regions, Genetic
RNA, Long Noncoding
/ genetics
Triple Negative Breast Neoplasms
/ genetics
C1orf132
EMT
TNBC
breast cancer
lncRNA
miR-29
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
23 Jun 2021
23 Jun 2021
Historique:
received:
18
04
2021
revised:
25
05
2021
accepted:
02
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
17
7
2021
Statut:
epublish
Résumé
miR-29b2 and miR-29c play a suppressive role in breast cancer progression.
Identifiants
pubmed: 34201896
pii: ijms22136768
doi: 10.3390/ijms22136768
pmc: PMC8268529
pii:
doi:
Substances chimiques
MIRN29B1 microRNA, human
0
MIRN29C microRNA, human
0
MicroRNAs
0
RNA, Long Noncoding
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
PLoS One. 2014 Feb 11;9(2):e87780
pubmed: 24523873
Forensic Sci Int Genet. 2016 Sep;24:65-74
pubmed: 27337627
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
J Cell Sci. 2008 Mar 15;121(Pt 6):727-35
pubmed: 18322269
Oncotarget. 2015 Feb 20;6(5):2767-78
pubmed: 25605017
Exp Cell Res. 1998 Aug 25;243(1):150-60
pubmed: 9716459
Cell. 2013 Jul 3;154(1):61-74
pubmed: 23827675
Cell Rep. 2016 Jul 26;16(4):1166-1179
pubmed: 27396337
Int J Clin Exp Pathol. 2017 Jul 01;10(7):8031-8042
pubmed: 31966655
Mol Cell. 2011 Sep 16;43(6):904-14
pubmed: 21925379
Asian Pac J Cancer Prev. 2015;16(12):5049-52
pubmed: 26163639
Cancer Sci. 2009 Jun;100(6):1012-7
pubmed: 19320640
Tumour Biol. 2017 Mar;39(3):1010428317695010
pubmed: 28345453
PLoS One. 2014 Nov 10;9(11):e112541
pubmed: 25383624
Forensic Sci Int Genet. 2015 Jul;17:173-179
pubmed: 26026729
Oncol Rep. 2018 Dec;40(6):3645-3653
pubmed: 30542725
Nature. 1994 Dec 15;372(6507):679-83
pubmed: 7990960
Front Oncol. 2019 May 31;9:407
pubmed: 31214490
Int J Cancer. 2019 Oct 1;145(7):1874-1888
pubmed: 30843188
Mol Cancer. 2017 Jun 6;16(1):98
pubmed: 28587642
J Exp Zool. 2001 Nov 1;290(6):616-23
pubmed: 11748610
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Mech Dev. 2001 Sep;107(1-2):69-82
pubmed: 11520664
Oncogene. 2015 Sep 24;34(39):5003-11
pubmed: 25619839
Expert Rev Mol Diagn. 2019 Jul;19(7):599-611
pubmed: 31188645
J Cell Biochem. 2007 Apr 1;100(5):1100-8
pubmed: 17131363
Asian Pac J Cancer Prev. 2018 Jul 27;19(7):1767-1770
pubmed: 30049185
Am J Cancer Res. 2016 Sep 01;6(9):1864-1872
pubmed: 27725895
Nat Cell Biol. 2009 Dec;11(12):1487-95
pubmed: 19935649
PLoS One. 2015 Nov 05;10(11):e0142224
pubmed: 26539832
Oncotarget. 2017 Mar 21;8(12):19645-19660
pubmed: 28160548
Virchows Arch. 2014 Jul;465(1):1-14
pubmed: 24878755
Clin Exp Pharmacol Physiol. 2017 Apr;44(4):441-454
pubmed: 28063172
Front Med. 2019 Jun;13(3):330-343
pubmed: 29808251
Biomed Pharmacother. 2019 Feb;110:400-408
pubmed: 30530042
Curr Pharm Des. 2016;22(5):616-38
pubmed: 26825466
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Forensic Sci Int Genet. 2019 Jan;38:1-8
pubmed: 30300865
Endocr Relat Cancer. 2016 Jul;23(7):571-85
pubmed: 27323961
Sci Rep. 2019 Jun 10;9(1):8370
pubmed: 31182783